Trump HHS Official Found Dead; Ruled Suicide By ‘Multiple Blunt Force Injuries’

Daniel Best, a pharmaceutical executive who recently began working for the U.S. Department of Health and Human Services tasked with the goal of “lowering prescription drug prices” in the United States, was found dead with “multiple blunt force injuries” on November 1.

Now, his death has been ruled a “suicide.”

According to Washington, D.C. police, Best was found “unresponsive” near the garage door exit of an apartment building in D.C.’s Navy Yard neighborhood at 5:25 a.m. on Nov. 1, and was pronounced dead by medical personnel who responded to the scene.

After investigating for two weeks, the city’s Office of the Chief Medical Examiner has announced that Best died from multiple blunt force injuries and ruled his death a suicide.

The Chief Medical Examiner’s verdict raised questions among the health community, with many people refusing to believe Best killed himself by repeatedly hitting himself with a blunt object until he died.

“How does one kill themselves by hitting themselves with a blunt object? Repeatedly?”

Unfortunately, the medical examiner wouldn’t release further information.

In announcing his death, HHS Secretary Alex Azar said the 49-year-old former CVSHealth and Pfizer Pharmaceuticals executive agreed to work at HHS “out of a desire to serve the American people by making health care more affordable.

He brought his deep expertise and passion to this task with great humility and collegiality,” Azar’s statement said.

All of us who served with Dan at HHS and in the administration mourn his passing and extend our thoughts and prayers to his wife Lisa and the entire Best family at this difficult time.

Best is survived by his wife, Lisa, and three children.

As Sundance at the Conservative Treehouse has so aptly pointed out:

There are massive multinational interests inherently at risk from President Trump’s “America-First” economic and trade platform. Believe it or not, President Trump is up against an entire world economic establishment.

(This is an essential read for those who want to understand just how powerful the forces aligned against President Trump are, and why.)

A basic explanation goes something like this; truly global markets have been replaced over the past three decades by multinational corporations that now control pricing according to the wants and needs of the corporation and no longer the dynamics of supply and demand that regulate the free market equitably.

Products were formerly traded in actual free markets where supply and demand determined prices across the globe.  Allowing for currency adjustments, prices were largely consistent between countries.

Today, these multinational corporations have grown into global entities powerful enough to have purchased controlling interests in any single economic commodity.  Like, let’s say, pharmaceuticals.

These multinational corporations, and the multinational banks they align with, then lobby the political policymakers of each targeted nation to manipulate distribution and pricing within each nation.

Instead of the traditional ‘supply/demand’ equation determining prices within each country, the corporations determine what prices would maximize profits from each nation.

Hence, we see that President Trump, is right about the Americans he is representing paying more, often far more, than they otherwise would under a truly free economic system of free trade rather thanthe managed trade that globalists tell us is free.

This assessment was confirmed in an article from last December in the Huffington Post:

The drug companies hold the power to charge America’s consumers whatever they want.Worse, Medicare — the nation’s largest purchaser of drugs — is prohibited by law from seeking better prices. The result of this short sighted policy is dramatic. In 2006, the first year of Medicare’s prescription drug program, the combined profits of the largest drug companies soared 34 percent to $76.3 billion. And unlike other industries, such as Big Oil, drug companies get something even better than a tax subsidy — they get a government program.

There are literally 100’s of billions of dollars at risk if President Trump puts an end to Big Pharma’s stranglehold on the market.

The 11 largest global drug companies made an astonishing $711 billion in profits over the 10 years ending in 2012, and they got a turbo-charged boost when the Medicare Part D prescription drug program started in 2006, according to an analysis of corporate filings by Health Care for America Now (HCAN).

See how this works?  See why the multinational-globalist kingpins are so stridently aligned against President Trump?  Have you noticed how much of their money has been spent trying to defame him and to defeat him?

Maybe now you might realize that the politicians you like, who are so abusive towards our president, are recipients of copious amounts of lobbying dollars and doing their bidding in ripping you off.

Against this backdrop, there exists a whole lot of incentive to make sure nothing changes.

According to HHS Secretary Azar, Daniel Best “brought his deep expertise and passion to this task with great humility and collegiality… out of a desire to serve the American people by making health care more affordable.”

You do the math.

Send this to a friend